Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA,
WHO, and other public sources. It is an independent information service, not a medical provider, and
not a substitute for professional medical advice or your local public health department's own guidance.
Policy version 2026-07-21, effective July 21, 2026.
If you are experiencing a medical emergency, call your local emergency services immediately. For food
recalls and disease investigations, always refer to the official CDC, FDA, USDA, WHO, or your local
public health authority for the most current information.
Based on the official records currently available to Public Health Trace, 5 recalls naming Mckesson Medical-Surgical Inc. Corporate Office are currently shown as ongoing. The other 152 records below are historical.
Public Health Trace has 157 recalls naming Mckesson Medical-Surgical Inc. Corporate Office as the recalling firm, republished from official FDA and USDA sources.
Recall records - 157 total
Recalls by year
A bar chart of the number of recalls naming this company by year.
FDA RecallTerminatedTerminated: November 30, 2023Historical recordClass II
Propofol Injectable Emulsion, USP, 200 mg/ 20 mL (10 mg/mL), packaged in a) 50 mL vial, in packs of 20 (NDC 00591-2136-51), b) 100 mL vial, in packs of 10 (NDC 00591-2136-68), Rx only, MFG: Teva Pharma USA
by Mckesson Medical-Surgical Inc. Corporate Office
FDA RecallTerminatedTerminated: November 30, 2023Historical recordClass II
MethyLPREDNISolone Acetate Injectable Suspension USP, 80 mg/mL, packaged in a) 1 mL single dose vial (NDC 0703-0051-01) b) 25-count box (NDC 0703-0051-04), Rx only, MFG: Teva Pharma USA
by Mckesson Medical-Surgical Inc. Corporate Office
FDA RecallTerminatedTerminated: November 30, 2023Historical recordClass II
MethyLPREDNISolone Acetate Injectable Suspension, USP, 40 mg/mL, packaged in a) 1 mL single dose vial (NDC 0703-0031-01), b) 25-count box (NDC 0703-0031-04), Rx only, MFG: Teva Pharma USA
by Mckesson Medical-Surgical Inc. Corporate Office
FDA RecallTerminatedTerminated: November 30, 2023Historical recordClass II
Medroxyprogesterone acetate injectable suspension, USP, 150 mg/mL, 1 mL vials, packaged in a) single dose vial (NDC 0703-6801-01), b) 25-count box single dose vials (NDC 0703-6801-04), Rx only, MFG: Teva Pharma USA
by Mckesson Medical-Surgical Inc. Corporate Office
Some FDA recall records on this page come from FDA's Enforcement Report database.
Not every Enforcement Report record has a separate FDA.gov recall-announcement page.
This page lists recalls that name Mckesson Medical-Surgical Inc. Corporate Office as the recalling firm in the official source notice. It is
not a safety rating, ranking, or statement that the company acted negligently.
Read the full medical disclaimer.
